Brief: Rubius Therapeutics Reports Q2 Loss Per Share $0.47

Rubius Therapeutics

10/08/2020 13:48

Aug 10 (Reuters) - Rubius Therapeutics Inc  RUBY.O :
    * RUBIUS THERAPEUTICS REPORTS SECOND QUARTER 2020 FINANCIAL
RESULTS AND POSITIVE PROGRESS ACROSS PIPELINE
    * Q2 LOSS PER SHARE $0.47
    * Q2 EARNINGS PER SHARE ESTIMATE $-0.50 -- REFINITIV IBES
DATA
    * INVESTIGATIONAL NEW DRUG APPLICATION ON TRACK BY YEAR-END
FOR
RTX-321 FOR HPV-POSITIVE CANCERS

Source text for Eikon:  ID:nGNXFDFSH 
Further company coverage:  RUBY.O 

 ((Reuters.Briefs@thomsonreuters.com;))